KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) EBIT (2016 - 2025)

Historic EBIT for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.

  • Thermo Fisher Scientific's EBIT rose 560.39% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.5 billion, marking a year-over-year increase of 462.72%. This contributed to the annual value of $7.3 billion for FY2024, which is 696.89% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported EBIT of $1.9 billion as of Q3 2025, which was up 560.39% from $1.8 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's EBIT ranged from a high of $3.0 billion in Q2 2021 and a low of $1.6 billion during Q2 2023
  • Over the past 5 years, Thermo Fisher Scientific's median EBIT value was $1.9 billion (recorded in 2022), while the average stood at $2.0 billion.
  • In the last 5 years, Thermo Fisher Scientific's EBIT surged by 23653.42% in 2021 and then plummeted by 4459.41% in 2023.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's EBIT stood at $2.5 billion in 2021, then fell by 26.67% to $1.9 billion in 2022, then decreased by 0.38% to $1.9 billion in 2023, then rose by 8.74% to $2.0 billion in 2024, then fell by 3.72% to $1.9 billion in 2025.
  • Its EBIT was $1.9 billion in Q3 2025, compared to $1.8 billion in Q2 2025 and $1.7 billion in Q1 2025.